AR and neoplasm: Still, mPCa is not curable; however, the number of available therapies to slow tumor progression significantly increased in the past few years, including chemotherapy even in earlier hormone-sensitive settings, anti-androgenic drug abiraterone [4], androgen receptor inhibitors like enzalutamide, apalutamide and darolutamide [5,6,7], and radium-223 [8].